BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23245408)

  • 1. Structural barriers to screening for and treatment of cervical cancer in Peru.
    Paz-Soldán VA; Bayer AM; Nussbaum L; Cabrera L
    Reprod Health Matters; 2012 Dec; 20(40):49-58. PubMed ID: 23245408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    Momberg M; Botha MH; Van der Merwe FH; Moodley J
    BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Accessible Cervical Cancer Screening in Peru-The Día del Mercado Project.
    Ferris DG; Shapiro J; Fowler C; Cutler C; Waller J; Guevara Condorhuaman WS
    J Low Genit Tract Dis; 2015 Jul; 19(3):229-33. PubMed ID: 25943865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missed opportunities for health education on Pap smears in Peru.
    Bayer AM; Nussbaum L; Cabrera L; Paz-Soldan VA
    Health Educ Behav; 2011 Apr; 38(2):198-209. PubMed ID: 21464205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is a once-in-a-lifetime pap smear the best option for low-resourced settings?
    Robles SC
    Int J Cancer; 2004 Aug; 111(1):160-1; discussion 162. PubMed ID: 15185358
    [No Abstract]   [Full Text] [Related]  

  • 8. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.
    Jovanovic V; Mitrovic Jovanovic A; Zivanovic A; Kocic S; Vasiljevic M; Krasic V
    Eur J Gynaecol Oncol; 2017; 38(1):69-75. PubMed ID: 29767868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 11. Barriers and Facilitators of Pap Testing for Women Living With HIV: A Focus Group Study.
    Jin S; Cudjoe J; Peay A; Baker D; Kunkel J; Sharps P; Han HR
    J Assoc Nurses AIDS Care; 2020; 31(2):190-196. PubMed ID: 31567730
    [No Abstract]   [Full Text] [Related]  

  • 12. The 'hows', 'whos', and 'whens' of screening: gynaecologists' perspectives on cervical cancer screening in urban Sweden.
    Sarkadi A; Widmark C; Törnberg S; Tishelman C
    Soc Sci Med; 2004 Mar; 58(6):1097-108. PubMed ID: 14723905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of Pap smear screening in the United States.
    Sirovich BE; Welch HG
    J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reimbursement Incentives to Improve Adherence to Follow-Up of Cervical Cancer Cytology Screening Results in Peru.
    Ferris DG; Chen J; Isaac A; Braithwaite E; Beideck E; Mikail N; Krotish D; Waller JL
    J Low Genit Tract Dis; 2019 Apr; 23(2):116-123. PubMed ID: 30741754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodic abstinence from Pap (PAP) smear study: women's perceptions of Pap smear screening.
    Smith M; French L; Barry HC
    Ann Fam Med; 2003; 1(4):203-8. PubMed ID: 15055409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Day or night, no matter what, I will go": Women's perspectives on challenges with follow-up care after cervical cancer screening in Iquitos, Peru: a qualitative study.
    Morse RM; Jurczuk M; Brown J; Jara LEC; Meza G; López EJR; Tracy JK; Gravitt PE; Paz-Soldan VA;
    BMC Womens Health; 2023 May; 23(1):293. PubMed ID: 37259075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.